Cyclosporine A is named as a drug or biological intervention in 2 clinical trials in our UK, USA and India trial registers, 2 of which are recruiting. Lead sponsors include Bristol-Myers Squibb (1) and University of California, San Francisco (1). Registered phase: Phase 3. Conditions studied include Renal Allograft Recipients; Fungal Keratitis; Corneal Ulcer.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT04877288 | A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications (ClinicalTrials.gov ↗) Renal Allograft Recipients |
Phase 3 | Recruiting |
| NCT06658002 | Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A Fungal Keratitis, Corneal Ulcer |
Phase 3 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Renal Allograft Recipients | 1 |
| Fungal Keratitis | 1 |
| Corneal Ulcer | 1 |
| Lead sponsor | Trials |
|---|---|
| Bristol-Myers Squibb | 1 |
| University of California, San Francisco | 1 |
| Register | Cyclosporine A trials |
|---|---|
| Clinical trials in UK | 1 |
| Clinical trials in USA | 1 |
| Clinical trials in India | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Cyclosporine A works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Cyclosporine A (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.